Viewing Study NCT00720603

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 7:19 PM

Ignite Modification Date: 2025-12-25 @ 4:58 PM

Study NCT ID: NCT00720603

Status: NO_LONGER_AVAILABLE

Last Update Posted: 2015-03-24

First Post: 2008-07-21

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: This is a Multi-center, Single Arm, Open Label Study Intended to Provide Expanded Access to Plerixafor for Patients With Non-Hodgkin's Lymphoma (NHL), Hodgkin's Disease (HD) or Multiple Myeloma (MM) Who Are to Receive Treatment With an Autologous Peripheral Stem Cell Transplant.

Sponsor: Genzyme, a Sanofi Company

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module